Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1627 of 6351
-
New antibody drug aims to slow lung scarring in IPF
Disease control Recruiting nowA Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 • Sponsor: Mediar Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New study aims to crack the code on cephalosporin allergies
Diagnosis Recruiting nowCephalosporin antibiotics are commonly used but can result in allergic reactions and anaphylaxis. There is no clear diagnostic approach for cephalosporin-allergic patients, and guidance for the use of other antibiotics in allergic patients is based on side chain chemical similari…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Immune cocktail takes on tough brain cancer in kids
Disease control Recruiting nowThis is a pilot study in a small number of children and young adults with suspected recurrent/progressive medulloblastoma (MB) looking at the feasibility and safety of adoptive cell therapy plus PD-1 blockade.
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a diabetes drug curb alcohol cravings in schizophrenia?
Disease control Recruiting nowGlucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for the treatment of type 2 diabetes and obesity, have shown promise as a novel treatment for alcohol use disorder (AUD). This study aims to investigate whether the Glucose-dependent Insulinotropic Polypeptide/GLP-1RA…
Phase 2 • Sponsor: Anders Fink-Jensen, MD, DMSci • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early phase oncology trial will be conducted at various study centers to investigate the safety, tolerability, and antitumor activity of STC-15 (a METTL3 inhibitor) in combination with toripalimab (anti- programmed cell death 1 \[PD-1\]) in advanced unresectable or metastati…
Phase 1/2 • Sponsor: STORM Therapeutics LTD • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Smart insulin system could ease diabetes management for type 2 patients
Disease control Recruiting nowThe aim of the study is to compare, in a population of patients with type 2 diabetes, open-loop insulin pump treatment with the CamAPS HX (Camdiab) Fully Closed Loop Automated Insulin Therapy system, on the efficacy and safety of use of the Fully Closed Loop, as well as on psycho…
Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Which exercise helps teens recover best from scoliosis surgery?
Disease control CompletedThis study aimed to comparatively examine the effects of different exercise training programs on kinesiophobia, functional capacity, disability level, neck injury status, balance, body health, and quality of life in adolescent individuals diagnosed with idiopathic scoliosis (AIS)…
Sponsor: NURSİMA İNCE • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a simple salt solution help donated kidneys work right away?
Disease control Recruiting nowEnd-stage renal disease (ESRD) is a significant clinical problem for which dialysis or transplantation is required. The current need for kidneys for transplantation vastly exceeds the supply available from live donors, necessitating the use of kidneys from deceased donors. Howeve…
Sponsor: Alp Sener • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could stem cells ease MS symptoms? new trial tests hope
Disease control OngoingThis protocol is part of a clinical study to evaluate efficacy and safety of multiple intravenous administrations of HB-adMSCs for the treatment of Multiple Sclerosis.
Phase 2 • Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a 'Goal-Plan-Do-Check' method help stroke survivors regain independence?
Disease control Recruiting nowThe goal of this clinical study is to examine the effectiveness of the Cognitive Orientation to daily Occupational Performance (CO-OP) in adults (18+) with accuired brain injury when applied in Danish rehabilitation context. The primary research question is: What is the effective…
Sponsor: Louise Møldrup Nielsen • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study aims to find best dose of heart drug to heal painful baby birthmarks
Disease control Recruiting nowThe main objective of this study was to determine the efficacy of different doses of propranolol in the treatment of ulcerattion infantile hemangioma (IH).
Phase 2/3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Family love as medicine: emotional stimulation shows promise for coma recovery
Symptom relief CompletedFamily-centered affective stimulation involves creating an environment in which family members actively participate in the patient's recovery by providing emotional support, positive reinforcement, and a supportive presence. The family-centered affective simulation effects on com…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
One-Shot radiation for recurrent prostate cancer: game changer or risky bet?
Disease control Recruiting nowRecently, the Radiation Oncology Department at Fondazione IRCCS San Gerardo dei Tintori has been renovated and has been equipped with cutting edge technologies to treat prostate cancer. Specifically, the now available technology can track organ motion in real time, thus allowing …
Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can brain zaps and hearing aids boost memory in seniors?
Symptom relief Recruiting nowThis study is a real-world interventional trial enrolling 189 participants: older adults with age-related hearing loss not using hearing aids (ARHL-nonHA), those using hearing aids (ARHL-HA), and those with normal hearing (HC). All groups will undergo hearing, cognitive (MMSE, Mo…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Could community groups curb diabetes? massive trial launches in pakistan
Disease control Recruiting nowThis project aims to adapt, implement, and evaluate Participatory Learning and Action (PLA) based intervention in rural areas of KPK, Pakistan which includes Peshawar and Swabi for TIIDM prevention and control. The pivotal components of this approach include adapting, implementin…
Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Jun 26, 2026 13:20 UTC
-
New program aims to cut dementia risk in care home residents
Prevention Recruiting nowDementia incidence is rising, posing a public health challenge, but 45% of cases can be prevented by addressing modifiable risk factors. Multidomain trials show that lifestyle changes can improve cognitive function and reduce dementia risk (like the FINGER trial). The REMINDER pr…
Sponsor: University of Coimbra • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Pee predicts cancer treatment success?
Knowledge-focused Recruiting nowThe goal of this observational study is to learn how well urinary proteins can predict treatment response in patients with locally advanced colorectal cancer (LACC) undergoing neoadjuvant therapy. The main question it aims to answer is: Can urinary protein markers help predict a…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Promising cocktail for tough cancer? early trial combines immunotherapy, targeted pill, and radiation
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of bemosubabimab combined with anlotinib and radiotherapy and chemotherapy in the treatment of patients with oligometastatic esophageal cancer. The study adopted a single-center, single-arm trial design. Eligible patients with …
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
AI boosts brain scan accuracy in massive new trial
Diagnosis By invitation onlyThis clinic trial aims to investigate whether artificial intelligence (AI) diagnostic tools at neurological diseases diagnosis on brain CT/MRI can improve the work efficiency of specialized neuroimaging physicians, with a specific focus on its clinical value in distinguishing nor…
Sponsor: Yaou Liu • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
A Longer-Lasting anemia shot: could pegmolesatide replace frequent dosing?
Disease control Recruiting nowThis was a multicenter, randomized, open label, non inferiority clinical study. It consisted of a 24-week treatment period (0-24 weeks) and a 24-week extension period (25-48 weeks). About 160 patients which had received Recombinant human erythropoietin (rHuEPO) or Hypoxia-inducib…
Phase 4 • Sponsor: The First Affiliated Hospital of Dalian Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC